Bifunctional Molecules: A Diverse New Modality That Unlocks New Target Classes
JN4025 Wuxi PROTAC Article Design Final_HR_no_crops
Related Content
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
VIEW RESOURCELooking for a solution to accelerate your drug discovery processes? WuXi AppTec's integrated Direct-to-Biology (D2B) platform is a cost-effective and...
VIEW RESOURCE